Review



human cbx6 cdna  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    OriGene human cbx6 cdna
    <t>CBX6</t> expression is downregulated in multiple cancer types (A) Statistical analysis of The Cancer Genome Atlas (TCGA) Pan-Cancer RNA sequencing (RNA-seq) database shows CBX6 expression is downregulated in various cancer types. (B) CBX6 expression is significantly suppressed in brain cancer, breast cancer, lung adenocarcinoma (abbreviated as LUAD), and prostate cancer, based on analysis of TCGA tumor microarray data using the BRowse All Variants Online (BRAVO) database method. (C and D) Comparison of CBX6 expression in patient-derived GBM tissues and primary tumor cells relative to respective normal controls using qRT-PCR. GAPDH was used as a loading control. (D) Reduced CBX6 expression is significantly associated with poor prognosis in patients with glioma, as shown in Kaplan-Meier survival curves derived from a public patient-derived microarray database, p = 1.94∗ e−7. PBT, primary brain tumor; RBT, recurrent brain tumor.
    Human Cbx6 Cdna, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cdna/CBX6+(NM_014292)+Human+Tagged+ORF+Clone/pmc13011037-187-8-25
    Average 94 stars, based on 4 article reviews
    human cbx6 cdna - by Bioz Stars, 2026-09
    94/100 stars

    Images

    1) Product Images from "CBX6 and CA9 as predictive indicators and therapeutic targets in GBM"

    Article Title: CBX6 and CA9 as predictive indicators and therapeutic targets in GBM

    Journal: Molecular Therapy Oncology

    doi: 10.1016/j.omton.2026.201159

    CBX6 expression is downregulated in multiple cancer types (A) Statistical analysis of The Cancer Genome Atlas (TCGA) Pan-Cancer RNA sequencing (RNA-seq) database shows CBX6 expression is downregulated in various cancer types. (B) CBX6 expression is significantly suppressed in brain cancer, breast cancer, lung adenocarcinoma (abbreviated as LUAD), and prostate cancer, based on analysis of TCGA tumor microarray data using the BRowse All Variants Online (BRAVO) database method. (C and D) Comparison of CBX6 expression in patient-derived GBM tissues and primary tumor cells relative to respective normal controls using qRT-PCR. GAPDH was used as a loading control. (D) Reduced CBX6 expression is significantly associated with poor prognosis in patients with glioma, as shown in Kaplan-Meier survival curves derived from a public patient-derived microarray database, p = 1.94∗ e−7. PBT, primary brain tumor; RBT, recurrent brain tumor.
    Figure Legend Snippet: CBX6 expression is downregulated in multiple cancer types (A) Statistical analysis of The Cancer Genome Atlas (TCGA) Pan-Cancer RNA sequencing (RNA-seq) database shows CBX6 expression is downregulated in various cancer types. (B) CBX6 expression is significantly suppressed in brain cancer, breast cancer, lung adenocarcinoma (abbreviated as LUAD), and prostate cancer, based on analysis of TCGA tumor microarray data using the BRowse All Variants Online (BRAVO) database method. (C and D) Comparison of CBX6 expression in patient-derived GBM tissues and primary tumor cells relative to respective normal controls using qRT-PCR. GAPDH was used as a loading control. (D) Reduced CBX6 expression is significantly associated with poor prognosis in patients with glioma, as shown in Kaplan-Meier survival curves derived from a public patient-derived microarray database, p = 1.94∗ e−7. PBT, primary brain tumor; RBT, recurrent brain tumor.

    Techniques Used: Expressing, RNA Sequencing, Microarray, Comparison, Derivative Assay, Quantitative RT-PCR, Control

    CBX6 modulation affects tumor cell morphology and proliferation (A) CBX6 modulation affects the morphology of U-251 MG cells in two-dimensional culture. (B) Downregulation of CBX6 increases growth and invasion of U-251 MG cells in 3D culture. (C) Overexpression of CBX6 significantly suppresses U-251 MG proliferation on days 3 and 5 post-plating, as measured by MTT assay. (D) MTT assay of KLuc cells stably overexpressing human CBX6 or transfected with control plasmid on days 3 and 5 post-plating. (E) Silencing CBX6 increases U-251 MG proliferation compared to shRNA controls. Images were captured randomly from different fields under 20× magnification. VC, vector control; OE, CBX6 overexpression; KD, CBX6 knockdown. “∗” indicated p < 0.05.
    Figure Legend Snippet: CBX6 modulation affects tumor cell morphology and proliferation (A) CBX6 modulation affects the morphology of U-251 MG cells in two-dimensional culture. (B) Downregulation of CBX6 increases growth and invasion of U-251 MG cells in 3D culture. (C) Overexpression of CBX6 significantly suppresses U-251 MG proliferation on days 3 and 5 post-plating, as measured by MTT assay. (D) MTT assay of KLuc cells stably overexpressing human CBX6 or transfected with control plasmid on days 3 and 5 post-plating. (E) Silencing CBX6 increases U-251 MG proliferation compared to shRNA controls. Images were captured randomly from different fields under 20× magnification. VC, vector control; OE, CBX6 overexpression; KD, CBX6 knockdown. “∗” indicated p < 0.05.

    Techniques Used: Over Expression, MTT Assay, Stable Transfection, Transfection, Control, Plasmid Preparation, shRNA, Knockdown

    Effects of CBX6 modulation on invasion and migration of U-251 MG cells (A and B) Representative images and cell quantification from transwell migration assays of U-251 MG cells with modulated CBX6 expression compared to corresponding controls. (C and D) Representative images and cell quantification from transwell invasion assays of U-251 MG cells with modulated CBX6 expression compared to respective controls. VC, vector control; OE, CBX6 overexpression; KD, CBX6 knockdown. “∗” Indicates p < 0.05.
    Figure Legend Snippet: Effects of CBX6 modulation on invasion and migration of U-251 MG cells (A and B) Representative images and cell quantification from transwell migration assays of U-251 MG cells with modulated CBX6 expression compared to corresponding controls. (C and D) Representative images and cell quantification from transwell invasion assays of U-251 MG cells with modulated CBX6 expression compared to respective controls. VC, vector control; OE, CBX6 overexpression; KD, CBX6 knockdown. “∗” Indicates p < 0.05.

    Techniques Used: Migration, Expressing, Plasmid Preparation, Control, Over Expression, Knockdown

    Effect of human CBX6 overexpression on glioma tumor growth (A and B) Bioluminescent imaging of NSG mice (A) and quantification of bioluminescence signal intensity as fold change (B) on days 4 and 8 ( n = 5). (C) Bioluminescent imaging at week 2 showing reduced Kluc tumor size in mice with human CBX6 overexpression compared to controls ( n = 10). (D and E) Kaplan-Meier survival analysis demonstrating that overexpression of human CBX6 in U-251 MG cells (D) ( n = 5) and Kluc cells (E) ( n = 10) improved mouse survival. (F) Histological analysis of tumor invasion and microsatellite metastasis in CBX6-overexpressing tumors. “∗” Indicates p < 0.05.
    Figure Legend Snippet: Effect of human CBX6 overexpression on glioma tumor growth (A and B) Bioluminescent imaging of NSG mice (A) and quantification of bioluminescence signal intensity as fold change (B) on days 4 and 8 ( n = 5). (C) Bioluminescent imaging at week 2 showing reduced Kluc tumor size in mice with human CBX6 overexpression compared to controls ( n = 10). (D and E) Kaplan-Meier survival analysis demonstrating that overexpression of human CBX6 in U-251 MG cells (D) ( n = 5) and Kluc cells (E) ( n = 10) improved mouse survival. (F) Histological analysis of tumor invasion and microsatellite metastasis in CBX6-overexpressing tumors. “∗” Indicates p < 0.05.

    Techniques Used: Over Expression, Imaging

    CBX6 binds to the CA9 promoter (A) Genes related to tumor cell invasion, proliferation, or migration were selected based on RNA sequencing data from U-251 MG cells with CBX6 knockdown compared to negative controls. (B) qRT-PCR results show that CA9 expression is affected by CBX6 dysregulation in U-251 MG cells, with overexpression or shRNA-mediated knockdown of CBX6, using GAPDH as a reference gene. (C) Gene expression correlation analysis from CGGA reveals an inverse relationship between CBX6 and CA9 expression patterns ( http://www.cgga.org.cn ). (D) Western blot and qRT-PCR data demonstrate changes in CBX6 and CA9 expression in U-251 MG and PBT030 cells under normoxic (N) and hypoxic (H) conditions for 24 and 48 h, using 28S as a reference gene. (E) ChIP assay results from CBX6-overexpressing U-251 MG cells show detection of the CA9 promoter sequence using two primer sets in CBX6/Flag pull-down products compared to a negative IgG control via qRT-PCR. VC, vector control; OE, CBX6 overexpression; KD, CBX6 knockdown. “∗” Indicates p < 0.05.
    Figure Legend Snippet: CBX6 binds to the CA9 promoter (A) Genes related to tumor cell invasion, proliferation, or migration were selected based on RNA sequencing data from U-251 MG cells with CBX6 knockdown compared to negative controls. (B) qRT-PCR results show that CA9 expression is affected by CBX6 dysregulation in U-251 MG cells, with overexpression or shRNA-mediated knockdown of CBX6, using GAPDH as a reference gene. (C) Gene expression correlation analysis from CGGA reveals an inverse relationship between CBX6 and CA9 expression patterns ( http://www.cgga.org.cn ). (D) Western blot and qRT-PCR data demonstrate changes in CBX6 and CA9 expression in U-251 MG and PBT030 cells under normoxic (N) and hypoxic (H) conditions for 24 and 48 h, using 28S as a reference gene. (E) ChIP assay results from CBX6-overexpressing U-251 MG cells show detection of the CA9 promoter sequence using two primer sets in CBX6/Flag pull-down products compared to a negative IgG control via qRT-PCR. VC, vector control; OE, CBX6 overexpression; KD, CBX6 knockdown. “∗” Indicates p < 0.05.

    Techniques Used: Migration, RNA Sequencing, Knockdown, Quantitative RT-PCR, Expressing, Over Expression, shRNA, Gene Expression, Western Blot, Sequencing, Control, Plasmid Preparation

    Related Articles

    Over Expression:

    Article Title: Improvement of Chloride Transport Defect by Gonadotropin-Releasing Hormone (GnRH) in Cystic Fibrosis Epithelial Cells
    Article Snippet: Cells were treated with 10 −9 M synthetic GnRH ([Gly-OH10]-LH-RH) from Sigma-Aldrich (Saint-Louis, MO, USA) for 30, 60, 120, 180 and 310 min. .. For GnRH-R overexpression and inhibition, cells were transfected using Lipofectamine 2000 (Life Technologies Corporation, Carlsbad, CA, USA), according to the manufacturer’s instructions, with either the human cDNA clone pCMV6-XL5/GNRH-R (OriGene Technologies Inc., Rockville, MD, USA) or the human GnRH-R siRNA (5′-GGAAUUUGGUAUUGGUUUG-3′, siGENOME individual duplex (Thermo Fisher Scientific Inc., Waltham, MA, USA). .. The scrambled control siRNA was siGENOME Non-Targeting (Thermo Fisher Scientific Inc.).

    Inhibition:

    Article Title: Improvement of Chloride Transport Defect by Gonadotropin-Releasing Hormone (GnRH) in Cystic Fibrosis Epithelial Cells
    Article Snippet: Cells were treated with 10 −9 M synthetic GnRH ([Gly-OH10]-LH-RH) from Sigma-Aldrich (Saint-Louis, MO, USA) for 30, 60, 120, 180 and 310 min. .. For GnRH-R overexpression and inhibition, cells were transfected using Lipofectamine 2000 (Life Technologies Corporation, Carlsbad, CA, USA), according to the manufacturer’s instructions, with either the human cDNA clone pCMV6-XL5/GNRH-R (OriGene Technologies Inc., Rockville, MD, USA) or the human GnRH-R siRNA (5′-GGAAUUUGGUAUUGGUUUG-3′, siGENOME individual duplex (Thermo Fisher Scientific Inc., Waltham, MA, USA). .. The scrambled control siRNA was siGENOME Non-Targeting (Thermo Fisher Scientific Inc.).

    Transfection:

    Article Title: Improvement of Chloride Transport Defect by Gonadotropin-Releasing Hormone (GnRH) in Cystic Fibrosis Epithelial Cells
    Article Snippet: Cells were treated with 10 −9 M synthetic GnRH ([Gly-OH10]-LH-RH) from Sigma-Aldrich (Saint-Louis, MO, USA) for 30, 60, 120, 180 and 310 min. .. For GnRH-R overexpression and inhibition, cells were transfected using Lipofectamine 2000 (Life Technologies Corporation, Carlsbad, CA, USA), according to the manufacturer’s instructions, with either the human cDNA clone pCMV6-XL5/GNRH-R (OriGene Technologies Inc., Rockville, MD, USA) or the human GnRH-R siRNA (5′-GGAAUUUGGUAUUGGUUUG-3′, siGENOME individual duplex (Thermo Fisher Scientific Inc., Waltham, MA, USA). .. The scrambled control siRNA was siGENOME Non-Targeting (Thermo Fisher Scientific Inc.).

    Amplification:

    Article Title: Non-vesicular phosphatidylinositol transfer plays critical roles in defining organelle lipid composition
    Article Snippet: .. EGFP-GOLPH3 was amplified by PCR amplification from a human cDNA clone (SC112810, NM_022130.3 ) purchased from ORIGENE using primers containing XhoI and EcoRI restriction sites to insert into the pEGFP-C1 plasmid. ..

    Article Title: Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells
    Article Snippet: A cDNA segment encoding the extracellular region of human Podoplanin (amino acids 23–131) was amplified by PCR using MGC clone 4876446 (Open Biosystems) as a template and inserted into pSecTag2B-Fc-FLAG at the HindIII/NotI sites. cDNA segments encoding full-length human Tie1 (amino acids 1–1138) and Tie2 (amino acids 1–1124) were obtained by RT-PCR using RNA extracted from human LECs and inserted with a cDNA segment encoding C-terminal FLAG tag (DYKDDDDK) or HA tag (YPYDVPDYA), respectively, into the pcDNA3.1 vector at the KpnI/ApaI sites. .. The expression vector for COMP-Ang1 was constructed as follows: a cDNA segment encoding human Ang1 linker and fibrinogen-like domain (amino acids 255–498) was amplified by PCR using human cDNA clone SC111587 (OriGene Technologies) as a template and inserted into pSecTag2B at the HindIII/ApaI sites with the cDNA segment encoding an N-terminal FLAG tag and a short coiled-coil domain of human cartilage oligomeric matrix protein (COMP; amino acids 28–73, amplified by PCR using synthetic primers; ). .. Recombinant Polydom, Polydom fragments, FLAG-tagged Fc-fusion proteins, and FLAG-tagged COMP-Ang1 were produced using a Freestyle 293 Expression System (Thermo Fisher Scientific).

    Article Title: Non-vesicular phosphatidylinositol transfer plays critical roles in defining organelle lipid composition.
    Article Snippet: .. EGFP-GOLPH3 was amplified by PCR amplification from a human cDNA clone (SC112810, NM_022130.3) purchased from ORIGENE using primers containing XhoI and EcoRI restriction sites to insert into the pEGFP-C1 plasmid. ..

    Article Title: Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells.
    Article Snippet: A cDNA segment encoding the extracellular region of human Podoplanin (amino acids 23–131) was amplified by PCR using MGC clone 4876446 (Open Biosystems) as a template and inserted into pSecTag2B-Fc-FLAG at the HindIII/NotI sites. cDNA segments encoding full-length human Tie1 (amino acids 1–1138) and Tie2 (amino acids 1–1124) were obtained by RT-PCR using RNA extracted from human LECs and inserted with a cDNA segment encoding C-terminal FLAG tag (DYKDDDDK) or HA tag (YPYDVPDYA), respectively, into the pcDNA3.1 vector at the KpnI/ApaI sites. .. The expression vector for COMP-Ang1 was constructed as follows: a cDNA segment encoding human Ang1 linker and fibrinogen-like domain (amino acids 255–498) was amplified by PCR using human cDNA clone SC111587 (OriGene Technologies) as a template and inserted into pSecTag2B at the HindIII/ApaI sites with the cDNA segment encoding an N-terminal FLAG tag and a short coiled-coil domain of human cartilage oligomeric matrix protein (COMP; amino acids 28–73, amplified by PCR using synthetic primers; Cho et al., 2004). .. Expression and purification of recombinant proteins Recombinant Polydom, Polydom fragments, FLAG-tagged Fcfusion proteins, and FLAG-tagged COMP-Ang1 were produced using a Freestyle 293 Expression System (Thermo Fisher Scientific).

    Polymerase Chain Reaction:

    Article Title: Non-vesicular phosphatidylinositol transfer plays critical roles in defining organelle lipid composition
    Article Snippet: .. EGFP-GOLPH3 was amplified by PCR amplification from a human cDNA clone (SC112810, NM_022130.3 ) purchased from ORIGENE using primers containing XhoI and EcoRI restriction sites to insert into the pEGFP-C1 plasmid. ..

    Article Title: Identification of a Lacosamide Binding Protein Using an Affinity Bait and Chemical Reporter Strategy: 14-3-3 ζ
    Article Snippet: .. 14-3-3 ζ was cloned from a human cDNA (RC209909, Origene) by use of the polymerase chain reaction and oligonucleotide primers specific from the cDNA sequence. .. The cloned fragment was inserted into the pET28b (Novagen) bacterial expression vector between NcoI and NotI restriction sites.

    Article Title: Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells
    Article Snippet: A cDNA segment encoding the extracellular region of human Podoplanin (amino acids 23–131) was amplified by PCR using MGC clone 4876446 (Open Biosystems) as a template and inserted into pSecTag2B-Fc-FLAG at the HindIII/NotI sites. cDNA segments encoding full-length human Tie1 (amino acids 1–1138) and Tie2 (amino acids 1–1124) were obtained by RT-PCR using RNA extracted from human LECs and inserted with a cDNA segment encoding C-terminal FLAG tag (DYKDDDDK) or HA tag (YPYDVPDYA), respectively, into the pcDNA3.1 vector at the KpnI/ApaI sites. .. The expression vector for COMP-Ang1 was constructed as follows: a cDNA segment encoding human Ang1 linker and fibrinogen-like domain (amino acids 255–498) was amplified by PCR using human cDNA clone SC111587 (OriGene Technologies) as a template and inserted into pSecTag2B at the HindIII/ApaI sites with the cDNA segment encoding an N-terminal FLAG tag and a short coiled-coil domain of human cartilage oligomeric matrix protein (COMP; amino acids 28–73, amplified by PCR using synthetic primers; ). .. Recombinant Polydom, Polydom fragments, FLAG-tagged Fc-fusion proteins, and FLAG-tagged COMP-Ang1 were produced using a Freestyle 293 Expression System (Thermo Fisher Scientific).

    Article Title: Non-vesicular phosphatidylinositol transfer plays critical roles in defining organelle lipid composition.
    Article Snippet: .. EGFP-GOLPH3 was amplified by PCR amplification from a human cDNA clone (SC112810, NM_022130.3) purchased from ORIGENE using primers containing XhoI and EcoRI restriction sites to insert into the pEGFP-C1 plasmid. ..

    Article Title: Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells.
    Article Snippet: A cDNA segment encoding the extracellular region of human Podoplanin (amino acids 23–131) was amplified by PCR using MGC clone 4876446 (Open Biosystems) as a template and inserted into pSecTag2B-Fc-FLAG at the HindIII/NotI sites. cDNA segments encoding full-length human Tie1 (amino acids 1–1138) and Tie2 (amino acids 1–1124) were obtained by RT-PCR using RNA extracted from human LECs and inserted with a cDNA segment encoding C-terminal FLAG tag (DYKDDDDK) or HA tag (YPYDVPDYA), respectively, into the pcDNA3.1 vector at the KpnI/ApaI sites. .. The expression vector for COMP-Ang1 was constructed as follows: a cDNA segment encoding human Ang1 linker and fibrinogen-like domain (amino acids 255–498) was amplified by PCR using human cDNA clone SC111587 (OriGene Technologies) as a template and inserted into pSecTag2B at the HindIII/ApaI sites with the cDNA segment encoding an N-terminal FLAG tag and a short coiled-coil domain of human cartilage oligomeric matrix protein (COMP; amino acids 28–73, amplified by PCR using synthetic primers; Cho et al., 2004). .. Expression and purification of recombinant proteins Recombinant Polydom, Polydom fragments, FLAG-tagged Fcfusion proteins, and FLAG-tagged COMP-Ang1 were produced using a Freestyle 293 Expression System (Thermo Fisher Scientific).

    Article Title: The Expression and Characterization of Functionally Active Soluble CD83 by Pichia pastoris Using High-Density Fermentation
    Article Snippet: .. Using the human cDNA clone pCMV6-XL4-CD83 (OriGene) as the template, the sCD83 gene was obtained by polymerase chain reaction (PCR) and inserted between the Xho I and EcoR I sites in pPIC9K and in-frame with the Kex2 cleavage site in the sequence of the α-factor secretion signal to create the expression vector pPIC9K-sCD83. ..

    Plasmid Preparation:

    Article Title: Non-vesicular phosphatidylinositol transfer plays critical roles in defining organelle lipid composition
    Article Snippet: .. EGFP-GOLPH3 was amplified by PCR amplification from a human cDNA clone (SC112810, NM_022130.3 ) purchased from ORIGENE using primers containing XhoI and EcoRI restriction sites to insert into the pEGFP-C1 plasmid. ..

    Article Title: Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells
    Article Snippet: A cDNA segment encoding the extracellular region of human Podoplanin (amino acids 23–131) was amplified by PCR using MGC clone 4876446 (Open Biosystems) as a template and inserted into pSecTag2B-Fc-FLAG at the HindIII/NotI sites. cDNA segments encoding full-length human Tie1 (amino acids 1–1138) and Tie2 (amino acids 1–1124) were obtained by RT-PCR using RNA extracted from human LECs and inserted with a cDNA segment encoding C-terminal FLAG tag (DYKDDDDK) or HA tag (YPYDVPDYA), respectively, into the pcDNA3.1 vector at the KpnI/ApaI sites. .. The expression vector for COMP-Ang1 was constructed as follows: a cDNA segment encoding human Ang1 linker and fibrinogen-like domain (amino acids 255–498) was amplified by PCR using human cDNA clone SC111587 (OriGene Technologies) as a template and inserted into pSecTag2B at the HindIII/ApaI sites with the cDNA segment encoding an N-terminal FLAG tag and a short coiled-coil domain of human cartilage oligomeric matrix protein (COMP; amino acids 28–73, amplified by PCR using synthetic primers; ). .. Recombinant Polydom, Polydom fragments, FLAG-tagged Fc-fusion proteins, and FLAG-tagged COMP-Ang1 were produced using a Freestyle 293 Expression System (Thermo Fisher Scientific).

    Article Title: Non-vesicular phosphatidylinositol transfer plays critical roles in defining organelle lipid composition.
    Article Snippet: .. EGFP-GOLPH3 was amplified by PCR amplification from a human cDNA clone (SC112810, NM_022130.3) purchased from ORIGENE using primers containing XhoI and EcoRI restriction sites to insert into the pEGFP-C1 plasmid. ..

    Article Title: Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells.
    Article Snippet: A cDNA segment encoding the extracellular region of human Podoplanin (amino acids 23–131) was amplified by PCR using MGC clone 4876446 (Open Biosystems) as a template and inserted into pSecTag2B-Fc-FLAG at the HindIII/NotI sites. cDNA segments encoding full-length human Tie1 (amino acids 1–1138) and Tie2 (amino acids 1–1124) were obtained by RT-PCR using RNA extracted from human LECs and inserted with a cDNA segment encoding C-terminal FLAG tag (DYKDDDDK) or HA tag (YPYDVPDYA), respectively, into the pcDNA3.1 vector at the KpnI/ApaI sites. .. The expression vector for COMP-Ang1 was constructed as follows: a cDNA segment encoding human Ang1 linker and fibrinogen-like domain (amino acids 255–498) was amplified by PCR using human cDNA clone SC111587 (OriGene Technologies) as a template and inserted into pSecTag2B at the HindIII/ApaI sites with the cDNA segment encoding an N-terminal FLAG tag and a short coiled-coil domain of human cartilage oligomeric matrix protein (COMP; amino acids 28–73, amplified by PCR using synthetic primers; Cho et al., 2004). .. Expression and purification of recombinant proteins Recombinant Polydom, Polydom fragments, FLAG-tagged Fcfusion proteins, and FLAG-tagged COMP-Ang1 were produced using a Freestyle 293 Expression System (Thermo Fisher Scientific).

    Article Title: The Expression and Characterization of Functionally Active Soluble CD83 by Pichia pastoris Using High-Density Fermentation
    Article Snippet: .. Using the human cDNA clone pCMV6-XL4-CD83 (OriGene) as the template, the sCD83 gene was obtained by polymerase chain reaction (PCR) and inserted between the Xho I and EcoR I sites in pPIC9K and in-frame with the Kex2 cleavage site in the sequence of the α-factor secretion signal to create the expression vector pPIC9K-sCD83. ..

    Clone Assay:

    Article Title: Identification of a Lacosamide Binding Protein Using an Affinity Bait and Chemical Reporter Strategy: 14-3-3 ζ
    Article Snippet: .. 14-3-3 ζ was cloned from a human cDNA (RC209909, Origene) by use of the polymerase chain reaction and oligonucleotide primers specific from the cDNA sequence. .. The cloned fragment was inserted into the pET28b (Novagen) bacterial expression vector between NcoI and NotI restriction sites.

    Sequencing:

    Article Title: Identification of a Lacosamide Binding Protein Using an Affinity Bait and Chemical Reporter Strategy: 14-3-3 ζ
    Article Snippet: .. 14-3-3 ζ was cloned from a human cDNA (RC209909, Origene) by use of the polymerase chain reaction and oligonucleotide primers specific from the cDNA sequence. .. The cloned fragment was inserted into the pET28b (Novagen) bacterial expression vector between NcoI and NotI restriction sites.

    Article Title: The Expression and Characterization of Functionally Active Soluble CD83 by Pichia pastoris Using High-Density Fermentation
    Article Snippet: .. Using the human cDNA clone pCMV6-XL4-CD83 (OriGene) as the template, the sCD83 gene was obtained by polymerase chain reaction (PCR) and inserted between the Xho I and EcoR I sites in pPIC9K and in-frame with the Kex2 cleavage site in the sequence of the α-factor secretion signal to create the expression vector pPIC9K-sCD83. ..

    Expressing:

    Article Title: Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells
    Article Snippet: A cDNA segment encoding the extracellular region of human Podoplanin (amino acids 23–131) was amplified by PCR using MGC clone 4876446 (Open Biosystems) as a template and inserted into pSecTag2B-Fc-FLAG at the HindIII/NotI sites. cDNA segments encoding full-length human Tie1 (amino acids 1–1138) and Tie2 (amino acids 1–1124) were obtained by RT-PCR using RNA extracted from human LECs and inserted with a cDNA segment encoding C-terminal FLAG tag (DYKDDDDK) or HA tag (YPYDVPDYA), respectively, into the pcDNA3.1 vector at the KpnI/ApaI sites. .. The expression vector for COMP-Ang1 was constructed as follows: a cDNA segment encoding human Ang1 linker and fibrinogen-like domain (amino acids 255–498) was amplified by PCR using human cDNA clone SC111587 (OriGene Technologies) as a template and inserted into pSecTag2B at the HindIII/ApaI sites with the cDNA segment encoding an N-terminal FLAG tag and a short coiled-coil domain of human cartilage oligomeric matrix protein (COMP; amino acids 28–73, amplified by PCR using synthetic primers; ). .. Recombinant Polydom, Polydom fragments, FLAG-tagged Fc-fusion proteins, and FLAG-tagged COMP-Ang1 were produced using a Freestyle 293 Expression System (Thermo Fisher Scientific).

    Article Title: Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells.
    Article Snippet: A cDNA segment encoding the extracellular region of human Podoplanin (amino acids 23–131) was amplified by PCR using MGC clone 4876446 (Open Biosystems) as a template and inserted into pSecTag2B-Fc-FLAG at the HindIII/NotI sites. cDNA segments encoding full-length human Tie1 (amino acids 1–1138) and Tie2 (amino acids 1–1124) were obtained by RT-PCR using RNA extracted from human LECs and inserted with a cDNA segment encoding C-terminal FLAG tag (DYKDDDDK) or HA tag (YPYDVPDYA), respectively, into the pcDNA3.1 vector at the KpnI/ApaI sites. .. The expression vector for COMP-Ang1 was constructed as follows: a cDNA segment encoding human Ang1 linker and fibrinogen-like domain (amino acids 255–498) was amplified by PCR using human cDNA clone SC111587 (OriGene Technologies) as a template and inserted into pSecTag2B at the HindIII/ApaI sites with the cDNA segment encoding an N-terminal FLAG tag and a short coiled-coil domain of human cartilage oligomeric matrix protein (COMP; amino acids 28–73, amplified by PCR using synthetic primers; Cho et al., 2004). .. Expression and purification of recombinant proteins Recombinant Polydom, Polydom fragments, FLAG-tagged Fcfusion proteins, and FLAG-tagged COMP-Ang1 were produced using a Freestyle 293 Expression System (Thermo Fisher Scientific).

    Article Title: The Expression and Characterization of Functionally Active Soluble CD83 by Pichia pastoris Using High-Density Fermentation
    Article Snippet: .. Using the human cDNA clone pCMV6-XL4-CD83 (OriGene) as the template, the sCD83 gene was obtained by polymerase chain reaction (PCR) and inserted between the Xho I and EcoR I sites in pPIC9K and in-frame with the Kex2 cleavage site in the sequence of the α-factor secretion signal to create the expression vector pPIC9K-sCD83. ..

    Construct:

    Article Title: Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells
    Article Snippet: A cDNA segment encoding the extracellular region of human Podoplanin (amino acids 23–131) was amplified by PCR using MGC clone 4876446 (Open Biosystems) as a template and inserted into pSecTag2B-Fc-FLAG at the HindIII/NotI sites. cDNA segments encoding full-length human Tie1 (amino acids 1–1138) and Tie2 (amino acids 1–1124) were obtained by RT-PCR using RNA extracted from human LECs and inserted with a cDNA segment encoding C-terminal FLAG tag (DYKDDDDK) or HA tag (YPYDVPDYA), respectively, into the pcDNA3.1 vector at the KpnI/ApaI sites. .. The expression vector for COMP-Ang1 was constructed as follows: a cDNA segment encoding human Ang1 linker and fibrinogen-like domain (amino acids 255–498) was amplified by PCR using human cDNA clone SC111587 (OriGene Technologies) as a template and inserted into pSecTag2B at the HindIII/ApaI sites with the cDNA segment encoding an N-terminal FLAG tag and a short coiled-coil domain of human cartilage oligomeric matrix protein (COMP; amino acids 28–73, amplified by PCR using synthetic primers; ). .. Recombinant Polydom, Polydom fragments, FLAG-tagged Fc-fusion proteins, and FLAG-tagged COMP-Ang1 were produced using a Freestyle 293 Expression System (Thermo Fisher Scientific).

    Article Title: Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells.
    Article Snippet: A cDNA segment encoding the extracellular region of human Podoplanin (amino acids 23–131) was amplified by PCR using MGC clone 4876446 (Open Biosystems) as a template and inserted into pSecTag2B-Fc-FLAG at the HindIII/NotI sites. cDNA segments encoding full-length human Tie1 (amino acids 1–1138) and Tie2 (amino acids 1–1124) were obtained by RT-PCR using RNA extracted from human LECs and inserted with a cDNA segment encoding C-terminal FLAG tag (DYKDDDDK) or HA tag (YPYDVPDYA), respectively, into the pcDNA3.1 vector at the KpnI/ApaI sites. .. The expression vector for COMP-Ang1 was constructed as follows: a cDNA segment encoding human Ang1 linker and fibrinogen-like domain (amino acids 255–498) was amplified by PCR using human cDNA clone SC111587 (OriGene Technologies) as a template and inserted into pSecTag2B at the HindIII/ApaI sites with the cDNA segment encoding an N-terminal FLAG tag and a short coiled-coil domain of human cartilage oligomeric matrix protein (COMP; amino acids 28–73, amplified by PCR using synthetic primers; Cho et al., 2004). .. Expression and purification of recombinant proteins Recombinant Polydom, Polydom fragments, FLAG-tagged Fcfusion proteins, and FLAG-tagged COMP-Ang1 were produced using a Freestyle 293 Expression System (Thermo Fisher Scientific).

    FLAG-tag:

    Article Title: Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells
    Article Snippet: A cDNA segment encoding the extracellular region of human Podoplanin (amino acids 23–131) was amplified by PCR using MGC clone 4876446 (Open Biosystems) as a template and inserted into pSecTag2B-Fc-FLAG at the HindIII/NotI sites. cDNA segments encoding full-length human Tie1 (amino acids 1–1138) and Tie2 (amino acids 1–1124) were obtained by RT-PCR using RNA extracted from human LECs and inserted with a cDNA segment encoding C-terminal FLAG tag (DYKDDDDK) or HA tag (YPYDVPDYA), respectively, into the pcDNA3.1 vector at the KpnI/ApaI sites. .. The expression vector for COMP-Ang1 was constructed as follows: a cDNA segment encoding human Ang1 linker and fibrinogen-like domain (amino acids 255–498) was amplified by PCR using human cDNA clone SC111587 (OriGene Technologies) as a template and inserted into pSecTag2B at the HindIII/ApaI sites with the cDNA segment encoding an N-terminal FLAG tag and a short coiled-coil domain of human cartilage oligomeric matrix protein (COMP; amino acids 28–73, amplified by PCR using synthetic primers; ). .. Recombinant Polydom, Polydom fragments, FLAG-tagged Fc-fusion proteins, and FLAG-tagged COMP-Ang1 were produced using a Freestyle 293 Expression System (Thermo Fisher Scientific).

    Article Title: Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells.
    Article Snippet: A cDNA segment encoding the extracellular region of human Podoplanin (amino acids 23–131) was amplified by PCR using MGC clone 4876446 (Open Biosystems) as a template and inserted into pSecTag2B-Fc-FLAG at the HindIII/NotI sites. cDNA segments encoding full-length human Tie1 (amino acids 1–1138) and Tie2 (amino acids 1–1124) were obtained by RT-PCR using RNA extracted from human LECs and inserted with a cDNA segment encoding C-terminal FLAG tag (DYKDDDDK) or HA tag (YPYDVPDYA), respectively, into the pcDNA3.1 vector at the KpnI/ApaI sites. .. The expression vector for COMP-Ang1 was constructed as follows: a cDNA segment encoding human Ang1 linker and fibrinogen-like domain (amino acids 255–498) was amplified by PCR using human cDNA clone SC111587 (OriGene Technologies) as a template and inserted into pSecTag2B at the HindIII/ApaI sites with the cDNA segment encoding an N-terminal FLAG tag and a short coiled-coil domain of human cartilage oligomeric matrix protein (COMP; amino acids 28–73, amplified by PCR using synthetic primers; Cho et al., 2004). .. Expression and purification of recombinant proteins Recombinant Polydom, Polydom fragments, FLAG-tagged Fcfusion proteins, and FLAG-tagged COMP-Ang1 were produced using a Freestyle 293 Expression System (Thermo Fisher Scientific).

    Transformation Assay:

    Article Title: Omega-3 Fatty Acid Derived Neuroactive Lipids - Docosahexaenoyl-Glycine and Its Epoxide Metabolites are Multifunctional Lipid Mediators
    Article Snippet: .. tGFP-FAAH was obtained from Origene (CAT#: RG210331). tGFP-FAAH is a human cDNA clone of fatty acid amide hydrolase (Accession Number: NM_001441 ) containing a tGFP tag. tGFP tag is a turbo GFP, which is a small but highly fluorescent GFP. tGFP-FAAH was transformed in DH5α E. Coli , expanded, and DNA isolated. .. DNA was then utilized for transfection in HEK293 cells using Calfectin (SignaGen CAT#: SL100478) according to manufacturer guidelines.

    Isolation:

    Article Title: Omega-3 Fatty Acid Derived Neuroactive Lipids - Docosahexaenoyl-Glycine and Its Epoxide Metabolites are Multifunctional Lipid Mediators
    Article Snippet: .. tGFP-FAAH was obtained from Origene (CAT#: RG210331). tGFP-FAAH is a human cDNA clone of fatty acid amide hydrolase (Accession Number: NM_001441 ) containing a tGFP tag. tGFP tag is a turbo GFP, which is a small but highly fluorescent GFP. tGFP-FAAH was transformed in DH5α E. Coli , expanded, and DNA isolated. .. DNA was then utilized for transfection in HEK293 cells using Calfectin (SignaGen CAT#: SL100478) according to manufacturer guidelines.



    Similar Products

    93
    ATCC human il 15 cdna
    Human Il 15 Cdna, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cdna/human+CAV+cDNA/us12637659-222-3-10
    Average 93 stars, based on 1 article reviews
    human il 15 cdna - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Sino Biological human trim21 gene orf cdna clone expression plasmid, c-gfpspark tag
    Human Trim21 Gene Orf Cdna Clone Expression Plasmid, C Gfpspark Tag, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cdna/Human+TRIM21+Gene+ORF+cDNA+clone+expression+plasmid%2C+C-GFPSpark+tag/custom%40hg18010-acg%4042066836
    Average 93 stars, based on 1 article reviews
    human trim21 gene orf cdna clone expression plasmid, c-gfpspark tag - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    86
    Twist Bioscience human codon optimized ubap1 cdna
    Human Codon Optimized Ubap1 Cdna, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cdna/cdna+codon+human+optimized+ubap1/pm42236937-596-0-4
    Average 86 stars, based on 1 article reviews
    human codon optimized ubap1 cdna - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    94
    OriGene human cbx6 cdna
    <t>CBX6</t> expression is downregulated in multiple cancer types (A) Statistical analysis of The Cancer Genome Atlas (TCGA) Pan-Cancer RNA sequencing (RNA-seq) database shows CBX6 expression is downregulated in various cancer types. (B) CBX6 expression is significantly suppressed in brain cancer, breast cancer, lung adenocarcinoma (abbreviated as LUAD), and prostate cancer, based on analysis of TCGA tumor microarray data using the BRowse All Variants Online (BRAVO) database method. (C and D) Comparison of CBX6 expression in patient-derived GBM tissues and primary tumor cells relative to respective normal controls using qRT-PCR. GAPDH was used as a loading control. (D) Reduced CBX6 expression is significantly associated with poor prognosis in patients with glioma, as shown in Kaplan-Meier survival curves derived from a public patient-derived microarray database, p = 1.94∗ e−7. PBT, primary brain tumor; RBT, recurrent brain tumor.
    Human Cbx6 Cdna, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cdna/CBX6+(NM_014292)+Human+Tagged+ORF+Clone/pmc13011037-187-8-25
    Average 94 stars, based on 1 article reviews
    human cbx6 cdna - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    OriGene human fabp cdnas
    <t>CBX6</t> expression is downregulated in multiple cancer types (A) Statistical analysis of The Cancer Genome Atlas (TCGA) Pan-Cancer RNA sequencing (RNA-seq) database shows CBX6 expression is downregulated in various cancer types. (B) CBX6 expression is significantly suppressed in brain cancer, breast cancer, lung adenocarcinoma (abbreviated as LUAD), and prostate cancer, based on analysis of TCGA tumor microarray data using the BRowse All Variants Online (BRAVO) database method. (C and D) Comparison of CBX6 expression in patient-derived GBM tissues and primary tumor cells relative to respective normal controls using qRT-PCR. GAPDH was used as a loading control. (D) Reduced CBX6 expression is significantly associated with poor prognosis in patients with glioma, as shown in Kaplan-Meier survival curves derived from a public patient-derived microarray database, p = 1.94∗ e−7. PBT, primary brain tumor; RBT, recurrent brain tumor.
    Human Fabp Cdnas, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cdna/liver+FABP+(FABP1)+Rabbit+Polyclonal+Antibody/pm42247526-207-0-6
    Average 94 stars, based on 1 article reviews
    human fabp cdnas - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    91
    Sino Biological human pedf gene orf cdna clone expression plasmid, c-gfpspark tag
    <t>CBX6</t> expression is downregulated in multiple cancer types (A) Statistical analysis of The Cancer Genome Atlas (TCGA) Pan-Cancer RNA sequencing (RNA-seq) database shows CBX6 expression is downregulated in various cancer types. (B) CBX6 expression is significantly suppressed in brain cancer, breast cancer, lung adenocarcinoma (abbreviated as LUAD), and prostate cancer, based on analysis of TCGA tumor microarray data using the BRowse All Variants Online (BRAVO) database method. (C and D) Comparison of CBX6 expression in patient-derived GBM tissues and primary tumor cells relative to respective normal controls using qRT-PCR. GAPDH was used as a loading control. (D) Reduced CBX6 expression is significantly associated with poor prognosis in patients with glioma, as shown in Kaplan-Meier survival curves derived from a public patient-derived microarray database, p = 1.94∗ e−7. PBT, primary brain tumor; RBT, recurrent brain tumor.
    Human Pedf Gene Orf Cdna Clone Expression Plasmid, C Gfpspark Tag, supplied by Sino Biological, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cdna/Human+PEDF+Gene+ORF+cDNA+clone+expression+plasmid%2C+C-GFPSpark+tag/custom%40hg11104-acg%4042070594
    Average 91 stars, based on 1 article reviews
    human pedf gene orf cdna clone expression plasmid, c-gfpspark tag - by Bioz Stars, 2026-09
    91/100 stars
      Buy from Supplier

    94
    OriGene healthy brain tissue
    <t>CBX6</t> expression is downregulated in multiple cancer types (A) Statistical analysis of The Cancer Genome Atlas (TCGA) Pan-Cancer RNA sequencing (RNA-seq) database shows CBX6 expression is downregulated in various cancer types. (B) CBX6 expression is significantly suppressed in brain cancer, breast cancer, lung adenocarcinoma (abbreviated as LUAD), and prostate cancer, based on analysis of TCGA tumor microarray data using the BRowse All Variants Online (BRAVO) database method. (C and D) Comparison of CBX6 expression in patient-derived GBM tissues and primary tumor cells relative to respective normal controls using qRT-PCR. GAPDH was used as a loading control. (D) Reduced CBX6 expression is significantly associated with poor prognosis in patients with glioma, as shown in Kaplan-Meier survival curves derived from a public patient-derived microarray database, p = 1.94∗ e−7. PBT, primary brain tumor; RBT, recurrent brain tumor.
    Healthy Brain Tissue, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cdna/TissueScan%2C+Human+Brain+cDNA+Array/pm42236120-298-30-39
    Average 94 stars, based on 1 article reviews
    healthy brain tissue - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    98
    MedChemExpress complementary dna cdna
    <t>CBX6</t> expression is downregulated in multiple cancer types (A) Statistical analysis of The Cancer Genome Atlas (TCGA) Pan-Cancer RNA sequencing (RNA-seq) database shows CBX6 expression is downregulated in various cancer types. (B) CBX6 expression is significantly suppressed in brain cancer, breast cancer, lung adenocarcinoma (abbreviated as LUAD), and prostate cancer, based on analysis of TCGA tumor microarray data using the BRowse All Variants Online (BRAVO) database method. (C and D) Comparison of CBX6 expression in patient-derived GBM tissues and primary tumor cells relative to respective normal controls using qRT-PCR. GAPDH was used as a loading control. (D) Reduced CBX6 expression is significantly associated with poor prognosis in patients with glioma, as shown in Kaplan-Meier survival curves derived from a public patient-derived microarray database, p = 1.94∗ e−7. PBT, primary brain tumor; RBT, recurrent brain tumor.
    Complementary Dna Cdna, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cdna/MPZL1%2C+Human/pmc13324582-84-0-15
    Average 98 stars, based on 1 article reviews
    complementary dna cdna - by Bioz Stars, 2026-09
    98/100 stars
      Buy from Supplier

    98
    MedChemExpress cdna
    <t>CBX6</t> expression is downregulated in multiple cancer types (A) Statistical analysis of The Cancer Genome Atlas (TCGA) Pan-Cancer RNA sequencing (RNA-seq) database shows CBX6 expression is downregulated in various cancer types. (B) CBX6 expression is significantly suppressed in brain cancer, breast cancer, lung adenocarcinoma (abbreviated as LUAD), and prostate cancer, based on analysis of TCGA tumor microarray data using the BRowse All Variants Online (BRAVO) database method. (C and D) Comparison of CBX6 expression in patient-derived GBM tissues and primary tumor cells relative to respective normal controls using qRT-PCR. GAPDH was used as a loading control. (D) Reduced CBX6 expression is significantly associated with poor prognosis in patients with glioma, as shown in Kaplan-Meier survival curves derived from a public patient-derived microarray database, p = 1.94∗ e−7. PBT, primary brain tumor; RBT, recurrent brain tumor.
    Cdna, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cdna/MPZL1%2C+Human/pmc13254702-87-17-15
    Average 98 stars, based on 1 article reviews
    cdna - by Bioz Stars, 2026-09
    98/100 stars
      Buy from Supplier

    Image Search Results


    CBX6 expression is downregulated in multiple cancer types (A) Statistical analysis of The Cancer Genome Atlas (TCGA) Pan-Cancer RNA sequencing (RNA-seq) database shows CBX6 expression is downregulated in various cancer types. (B) CBX6 expression is significantly suppressed in brain cancer, breast cancer, lung adenocarcinoma (abbreviated as LUAD), and prostate cancer, based on analysis of TCGA tumor microarray data using the BRowse All Variants Online (BRAVO) database method. (C and D) Comparison of CBX6 expression in patient-derived GBM tissues and primary tumor cells relative to respective normal controls using qRT-PCR. GAPDH was used as a loading control. (D) Reduced CBX6 expression is significantly associated with poor prognosis in patients with glioma, as shown in Kaplan-Meier survival curves derived from a public patient-derived microarray database, p = 1.94∗ e−7. PBT, primary brain tumor; RBT, recurrent brain tumor.

    Journal: Molecular Therapy Oncology

    Article Title: CBX6 and CA9 as predictive indicators and therapeutic targets in GBM

    doi: 10.1016/j.omton.2026.201159

    Figure Lengend Snippet: CBX6 expression is downregulated in multiple cancer types (A) Statistical analysis of The Cancer Genome Atlas (TCGA) Pan-Cancer RNA sequencing (RNA-seq) database shows CBX6 expression is downregulated in various cancer types. (B) CBX6 expression is significantly suppressed in brain cancer, breast cancer, lung adenocarcinoma (abbreviated as LUAD), and prostate cancer, based on analysis of TCGA tumor microarray data using the BRowse All Variants Online (BRAVO) database method. (C and D) Comparison of CBX6 expression in patient-derived GBM tissues and primary tumor cells relative to respective normal controls using qRT-PCR. GAPDH was used as a loading control. (D) Reduced CBX6 expression is significantly associated with poor prognosis in patients with glioma, as shown in Kaplan-Meier survival curves derived from a public patient-derived microarray database, p = 1.94∗ e−7. PBT, primary brain tumor; RBT, recurrent brain tumor.

    Article Snippet: A pCMV6-entry plasmid containing Myc-DDK (same as Flag)-tagged human CBX6 cDNA (Cat#: RC204166) and a CBX6 Human shRNA Plasmid Kit (Cat#: TF314170) were purchased from OriGene.

    Techniques: Expressing, RNA Sequencing, Microarray, Comparison, Derivative Assay, Quantitative RT-PCR, Control

    CBX6 modulation affects tumor cell morphology and proliferation (A) CBX6 modulation affects the morphology of U-251 MG cells in two-dimensional culture. (B) Downregulation of CBX6 increases growth and invasion of U-251 MG cells in 3D culture. (C) Overexpression of CBX6 significantly suppresses U-251 MG proliferation on days 3 and 5 post-plating, as measured by MTT assay. (D) MTT assay of KLuc cells stably overexpressing human CBX6 or transfected with control plasmid on days 3 and 5 post-plating. (E) Silencing CBX6 increases U-251 MG proliferation compared to shRNA controls. Images were captured randomly from different fields under 20× magnification. VC, vector control; OE, CBX6 overexpression; KD, CBX6 knockdown. “∗” indicated p < 0.05.

    Journal: Molecular Therapy Oncology

    Article Title: CBX6 and CA9 as predictive indicators and therapeutic targets in GBM

    doi: 10.1016/j.omton.2026.201159

    Figure Lengend Snippet: CBX6 modulation affects tumor cell morphology and proliferation (A) CBX6 modulation affects the morphology of U-251 MG cells in two-dimensional culture. (B) Downregulation of CBX6 increases growth and invasion of U-251 MG cells in 3D culture. (C) Overexpression of CBX6 significantly suppresses U-251 MG proliferation on days 3 and 5 post-plating, as measured by MTT assay. (D) MTT assay of KLuc cells stably overexpressing human CBX6 or transfected with control plasmid on days 3 and 5 post-plating. (E) Silencing CBX6 increases U-251 MG proliferation compared to shRNA controls. Images were captured randomly from different fields under 20× magnification. VC, vector control; OE, CBX6 overexpression; KD, CBX6 knockdown. “∗” indicated p < 0.05.

    Article Snippet: A pCMV6-entry plasmid containing Myc-DDK (same as Flag)-tagged human CBX6 cDNA (Cat#: RC204166) and a CBX6 Human shRNA Plasmid Kit (Cat#: TF314170) were purchased from OriGene.

    Techniques: Over Expression, MTT Assay, Stable Transfection, Transfection, Control, Plasmid Preparation, shRNA, Knockdown

    Effects of CBX6 modulation on invasion and migration of U-251 MG cells (A and B) Representative images and cell quantification from transwell migration assays of U-251 MG cells with modulated CBX6 expression compared to corresponding controls. (C and D) Representative images and cell quantification from transwell invasion assays of U-251 MG cells with modulated CBX6 expression compared to respective controls. VC, vector control; OE, CBX6 overexpression; KD, CBX6 knockdown. “∗” Indicates p < 0.05.

    Journal: Molecular Therapy Oncology

    Article Title: CBX6 and CA9 as predictive indicators and therapeutic targets in GBM

    doi: 10.1016/j.omton.2026.201159

    Figure Lengend Snippet: Effects of CBX6 modulation on invasion and migration of U-251 MG cells (A and B) Representative images and cell quantification from transwell migration assays of U-251 MG cells with modulated CBX6 expression compared to corresponding controls. (C and D) Representative images and cell quantification from transwell invasion assays of U-251 MG cells with modulated CBX6 expression compared to respective controls. VC, vector control; OE, CBX6 overexpression; KD, CBX6 knockdown. “∗” Indicates p < 0.05.

    Article Snippet: A pCMV6-entry plasmid containing Myc-DDK (same as Flag)-tagged human CBX6 cDNA (Cat#: RC204166) and a CBX6 Human shRNA Plasmid Kit (Cat#: TF314170) were purchased from OriGene.

    Techniques: Migration, Expressing, Plasmid Preparation, Control, Over Expression, Knockdown

    Effect of human CBX6 overexpression on glioma tumor growth (A and B) Bioluminescent imaging of NSG mice (A) and quantification of bioluminescence signal intensity as fold change (B) on days 4 and 8 ( n = 5). (C) Bioluminescent imaging at week 2 showing reduced Kluc tumor size in mice with human CBX6 overexpression compared to controls ( n = 10). (D and E) Kaplan-Meier survival analysis demonstrating that overexpression of human CBX6 in U-251 MG cells (D) ( n = 5) and Kluc cells (E) ( n = 10) improved mouse survival. (F) Histological analysis of tumor invasion and microsatellite metastasis in CBX6-overexpressing tumors. “∗” Indicates p < 0.05.

    Journal: Molecular Therapy Oncology

    Article Title: CBX6 and CA9 as predictive indicators and therapeutic targets in GBM

    doi: 10.1016/j.omton.2026.201159

    Figure Lengend Snippet: Effect of human CBX6 overexpression on glioma tumor growth (A and B) Bioluminescent imaging of NSG mice (A) and quantification of bioluminescence signal intensity as fold change (B) on days 4 and 8 ( n = 5). (C) Bioluminescent imaging at week 2 showing reduced Kluc tumor size in mice with human CBX6 overexpression compared to controls ( n = 10). (D and E) Kaplan-Meier survival analysis demonstrating that overexpression of human CBX6 in U-251 MG cells (D) ( n = 5) and Kluc cells (E) ( n = 10) improved mouse survival. (F) Histological analysis of tumor invasion and microsatellite metastasis in CBX6-overexpressing tumors. “∗” Indicates p < 0.05.

    Article Snippet: A pCMV6-entry plasmid containing Myc-DDK (same as Flag)-tagged human CBX6 cDNA (Cat#: RC204166) and a CBX6 Human shRNA Plasmid Kit (Cat#: TF314170) were purchased from OriGene.

    Techniques: Over Expression, Imaging

    CBX6 binds to the CA9 promoter (A) Genes related to tumor cell invasion, proliferation, or migration were selected based on RNA sequencing data from U-251 MG cells with CBX6 knockdown compared to negative controls. (B) qRT-PCR results show that CA9 expression is affected by CBX6 dysregulation in U-251 MG cells, with overexpression or shRNA-mediated knockdown of CBX6, using GAPDH as a reference gene. (C) Gene expression correlation analysis from CGGA reveals an inverse relationship between CBX6 and CA9 expression patterns ( http://www.cgga.org.cn ). (D) Western blot and qRT-PCR data demonstrate changes in CBX6 and CA9 expression in U-251 MG and PBT030 cells under normoxic (N) and hypoxic (H) conditions for 24 and 48 h, using 28S as a reference gene. (E) ChIP assay results from CBX6-overexpressing U-251 MG cells show detection of the CA9 promoter sequence using two primer sets in CBX6/Flag pull-down products compared to a negative IgG control via qRT-PCR. VC, vector control; OE, CBX6 overexpression; KD, CBX6 knockdown. “∗” Indicates p < 0.05.

    Journal: Molecular Therapy Oncology

    Article Title: CBX6 and CA9 as predictive indicators and therapeutic targets in GBM

    doi: 10.1016/j.omton.2026.201159

    Figure Lengend Snippet: CBX6 binds to the CA9 promoter (A) Genes related to tumor cell invasion, proliferation, or migration were selected based on RNA sequencing data from U-251 MG cells with CBX6 knockdown compared to negative controls. (B) qRT-PCR results show that CA9 expression is affected by CBX6 dysregulation in U-251 MG cells, with overexpression or shRNA-mediated knockdown of CBX6, using GAPDH as a reference gene. (C) Gene expression correlation analysis from CGGA reveals an inverse relationship between CBX6 and CA9 expression patterns ( http://www.cgga.org.cn ). (D) Western blot and qRT-PCR data demonstrate changes in CBX6 and CA9 expression in U-251 MG and PBT030 cells under normoxic (N) and hypoxic (H) conditions for 24 and 48 h, using 28S as a reference gene. (E) ChIP assay results from CBX6-overexpressing U-251 MG cells show detection of the CA9 promoter sequence using two primer sets in CBX6/Flag pull-down products compared to a negative IgG control via qRT-PCR. VC, vector control; OE, CBX6 overexpression; KD, CBX6 knockdown. “∗” Indicates p < 0.05.

    Article Snippet: A pCMV6-entry plasmid containing Myc-DDK (same as Flag)-tagged human CBX6 cDNA (Cat#: RC204166) and a CBX6 Human shRNA Plasmid Kit (Cat#: TF314170) were purchased from OriGene.

    Techniques: Migration, RNA Sequencing, Knockdown, Quantitative RT-PCR, Expressing, Over Expression, shRNA, Gene Expression, Western Blot, Sequencing, Control, Plasmid Preparation